Cause of death, by non-communicable diseases, ages 5-14 in Azerbaijan
Azerbaijan: Cause of death, by non-communicable diseases, ages 5-14 was 29.6% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 5-14 in Azerbaijan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 5-14.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 5-14 in Azerbaijan stood at 29.6%.
The figure is up 55.9% on the previous year and down 6.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14 in Azerbaijan peaked at 31.8% in 2010 and was at its lowest, 19.0%, in 2020.
Azerbaijan ranks 118th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14 in Azerbaijan, year by year
| Year | % of total deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 25.4% | — |
| 2010 | 31.8% | +24.8% |
| 2015 | 31.3% | -1.5% |
| 2019 | 31.5% | +0.5% |
| 2020 | 19.0% | -39.7% |
| 2021 | 29.6% | +55.9% |
Azerbaijan compared with similar countries
- Azerbaijan's 29.6% is below the median for upper middle income countries, which is 38.5%, 77% of the median. (55 countries reporting)
- Azerbaijan's 29.6% is below the median for Europe & Central Asia, which is 58.0%, 51% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 25.4% | 25.4% | 25.4% | 1 |
| 2010s | 31.5% | 31.3% | 31.8% | 3 |
| 2020s | 24.3% | 19.0% | 29.6% | 2 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14 in Azerbaijan?
- Cause of death, by non-communicable diseases, ages 5-14 in Azerbaijan was 29.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14 recorded in Azerbaijan?
- The highest recorded value was 31.8% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14 recorded in Azerbaijan?
- The lowest recorded value was 19.0% in 2020.
- How does Azerbaijan rank for cause of death, by non-communicable diseases, ages 5-14?
- Azerbaijan ranks 118th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14 rising or falling in Azerbaijan?
- Over the last ten years it is down 6.9%. The long-run trend across the full record is flat.
- Where does this Azerbaijan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.